Showing results (51-60 of 2,325) with videos related to
Sort By:
Pageof 233
Biochemical and Biophysical Research Communications|March 2, 1999
Low density lipoprotein (LDL)-mediated suppression of Lewis lung carcinoma in hypercholesterolemic LDL receptor-deficient miceV N Trieu, F M UckunCurrent Pharmaceutical Design|June 8, 2004
Therapeutic potential of inhibiting Bruton's tyrosine kinase, (BTK)A O Vassilev, F M UckunAnti-Cancer Drug Design|April 15, 2000
Structure-based design of potent inhibitors of EGF-receptor tyrosine kinase as anti-cancer agentsS Ghosh, R K Narla, Y Zheng, et al.Radiation Research|August 25, 2010
Augmentation of the antileukemia potency of total-body irradiation (TBI) by a novel P-site inhibitor of spleen tyrosine kinase (SYK)F M Uckun, I Dibirdik, S QaziAmerican Journal of Therapeutics|November 13, 2001
2,4,6-Trihydroxy-alpha-p-methoxyphenylacetophenone (Compound D-58) is a potent inhibitor of allergic reactionsR Malaviya, A Vassilev, F M UckunImmunity|August 25, 2001
Role of Janus kinase 3 in mast cell-mediated innate immunity against gram-negative bacteriaR Malaviya, C Navara, F M UckunThe Journal of Biological Chemistry|April 21, 2001
Binding interactions between the active center cleft of recombinant pokeweed antiviral protein and the alpha-sarcin/ricin stem loop of ribosomal RNAF Rajamohan, C Mao, F M UckunDermatology (Basel, Switzerland)|January 9, 2001
Anti-inflammatory activity of 2,4, 6-trihydroxy-alpha-p-methoxyphenyl-acetophenone (compound D-58)R Malaviya, R Malaviya, F M UckunThe Journal of Biological Chemistry|August 31, 2001
Crystal structure of Bruton's tyrosine kinase domain suggests a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemiaC Mao, M Zhou, F M UckunCurrent Pharmaceutical Design|May 17, 2007
Meta analysis of advanced cancer survival data using lognormal parametric fitting: a statistical method to identify effective treatment protocolsS Qazi, D DuMez, F M UckunPageof 233